Research Article
Changes of Cell Adhesion Molecules and T Cell Subset Populations in Acute Myeloid Leukemia Patients Undergoing Intravenous Administration of Cytarabine Supplemented with Idarubicin
Table 1
The clinical response rates of AML patients following intravenous administration of cytarabine supplemented with either idarubicin or daunorubicin.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||